Canada House Wellness Group Services
Canada House Wellness Group has defined its position in the Canadian Cannabis industry as an organization focused upon the delivery of evidence-based cannabinoid therapy. The first phase, accumulating patients and providing medical care, has evolved significantly. Marijuana for Trauma (our medical clinics), Knalysis Technologies (developers of our health outcomes analytics platform) and Abba Medix (hgranted by Health Canada a license to cultivate cannabis, pursuant to the Access to Cannabis for Medical Purposes Regulations “ACMPR”) have been integrated into the organization to provide the full continuum of care under Canada House Wellness Group. Our software platform enables us to deliver evidence-based cannabinoid therapy to our patients through our clinics, with Abba Medix supplying the strains of cannabis to our patients that our software platform has identified as most efficacious for treating our patients’ conditions.
A Centralized Approach to Restorative Health
Each of our 10 MFT clinics offers a very welcoming environment to those seeking an alternative approach to managing their conditions, a place where our clients can receive the guidance they need to begin changing their life for the better.
Our Knalysis Technologies Division complements MFT’s mission in the background through the development and maintenance of our cannabis patient management software, which securely maintains up-to-date health records for each MFT client. This patient management system, in conjunction with our smartphone app, will enable Canada House to collect anonymized, real-world patient data to develop disease-specific cannabinoid therapy treatment plans for our clients.
Our Abba Medix grow facility, recently granted by Health Canada a license to cultivate cannabis , will draw upon the tremendous knowledge of MFT and Knalysis – gained by working with thousands of clients over several years – to focus upon growing only the strains that best meet the needs of our clientele. Our clientele is our priority, and Abba Medix will soon be in a position to service these clients in a manner rooted in experience and medical evidence.